sur BioNxt Solutions Inc. (CVE:BNXT)
BioNxt Solutions Delays 2024 Annual Financial Statement Filing
BioNxt Solutions Inc., based in Vancouver, has announced a delay in filing its annual financial statements for the year ending December 31, 2024. The company cites delays in obtaining necessary financial information as the reason for not meeting the April 30, 2025 deadline. Efforts are underway to complete the filings by June 28, 2025.
A management cease trade order (MCTO) has been applied, restricting trading activities for the CEO and CFO until the filings are submitted. This MCTO requires completion by June 30, 2025. BioNxt plans to follow Alternative Information Guidelines to keep investors informed.
The company ensures no undisclosed material information exists, while affirming its commitment to enhancing healthcare through innovative solutions in drug delivery and pharmaceutical developments.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BioNxt Solutions Inc.